Reply to correspondence on "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction"

被引：1
|
作者：
Lee, Cho-Rong [1 ]
Park, Sung-Gyoo [1 ,2 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea
[2] Seoul Natl Univ, Res Inst Pharmaceut Sci, 1 Gwanak Ro, Seoul 08826, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 04期
基金：
新加坡国家研究基金会;
关键词：
Hepatitis B virus; CIITA; MHC class II;
D O I：
10.3350/cmh.2024.0572
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction
    Dezhbord, Mehrangiz
    Kim, Seong Ho
    Park, Soree
    Lee, Da Rae
    Kim, Nayeon
    Won, Juhee
    Lee, Ah Ram
    Kim, Dong-Sik
    Kim, Kyun-Hwan
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03)
  • [2] Correspondence on editorial regarding "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction"
    Dezhbord, Mehrangiz
    Kim, Kyun-Hwan
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [3] Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction(vol 30, pg 539, 2024)
    Dezhbord, Mehrangiz
    Kim, Seong Ho
    Park, Soree
    Lee, Da Rae
    Kim, Nayeon
    Won, Juhee
    Lee, Ah Ram
    Kim, Dong-Sik
    Kim, Kyun-Hwan
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [4] Class II transactivator restricts viral replication, ex-tending its effect to HBV: Editorial on "Novel role of MHC class II transactivator in hepatitis B virus replica-tion and viral counteraction"
    Lee, Cho-Rong
    Park, Sung-Gyoo
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [5] The MHC class II transactivator is a strong physiologic antagonist of HIV-1 replication
    Tosi, G
    Barbaro, ADL
    Mortara, L
    Accolla, RS
    TISSUE ANTIGENS, 2005, 66 (05): : 344 - 344
  • [6] Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene
    Peijnenburg, A
    Van den Berg, R
    Van Eggermond, MJCA
    Sanal, Ö
    Vossen, JMJJ
    Lennon, AM
    Alcaïde-Loridan, C
    Van den Elsen, PJ
    IMMUNOGENETICS, 2000, 51 (01) : 42 - 49
  • [7] Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator
    Lee, PT
    Holt, PG
    McWilliam, AS
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (08) : 2347 - 2356
  • [8] The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney
    Sims, TN
    Afrouzian, M
    Urmson, J
    Zhu, LF
    Halloran, PF
    AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (03) : 211 - 221
  • [9] Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene
    A. Peijnenburg
    R. Van den Berg
    M.J.C.A. Van Eggermond
    Ö. Sanal
    J. M. J. J. Vossen
    A. -M. Lennon
    C. Alcaïde-Loridan
    P.J. Van den Elsen
    Immunogenetics, 2000, 51 : 42 - 49
  • [10] The MHC class II transcriptional activator (CHTA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2
    Casoli, C
    Barbaro, AD
    Pilotti, E
    Bertazzoni, U
    Tosi, G
    Accolla, RS
    BLOOD, 2004, 103 (03) : 995 - 1001
12345